REPORT ID 1131

Global Neuromodulation Devices Sales Market Report 2017

Publish Date
05-Dec-17
Pages
107
Format
Electronic (PDF)

In this report, the global Neuromodulation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Neuromodulation Devices for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Neuromodulation Devices market competition by top manufacturers/players, with Neuromodulation Devices sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Medtronic
    Boston Scientific Corporation
    St.Jude Medical
    Synapse Biomedical
    Nevro
    Neurosigma
    Neuropace
    Neuronetics
    Cyberonics
    BioControl Medical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Deep Brain Stimulation (DBS) Systems
    Spinal Cord Stimulator (SCS) Systems
    Diaphragm Pacing System (DPS)
    Respiratory Electrical Stimulation (RES)
    Vagus Nerve Stimulation (VNS)
    Gastric Electrical Stimulation (GES)
    Transcranial Magnetic Stimulation (TMS)
    Transcutaneous Electrical Nerve Stimulation (TENS)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Chronic Pain
    Parkinson's Disease
    Urine Incontinence
    Epilepsy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Neuromodulation Devices Sales Market Report 2017
1 Neuromodulation Devices Market Overview
    1.1 Product Overview and Scope of Neuromodulation Devices
    1.2 Classification of Neuromodulation Devices by Product Category
        1.2.1 Global Neuromodulation Devices Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Neuromodulation Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Deep Brain Stimulation (DBS) Systems
        1.2.4 Spinal Cord Stimulator (SCS) Systems
        1.2.5 Diaphragm Pacing System (DPS)
        1.2.6 Respiratory Electrical Stimulation (RES)
        1.2.7 Vagus Nerve Stimulation (VNS)
        1.2.8 Gastric Electrical Stimulation (GES)
        1.2.9 Transcranial Magnetic Stimulation (TMS)
        1.2.10 Transcutaneous Electrical Nerve Stimulation (TENS)
    1.3 Global Neuromodulation Devices Market by Application/End Users
        1.3.1 Global Neuromodulation Devices Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Chronic Pain
        1.3.3 Parkinson's Disease
        1.3.4 Urine Incontinence
        1.3.5 Epilepsy
        1.3.6 Others
    1.4 Global Neuromodulation Devices Market by Region
        1.4.1 Global Neuromodulation Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.3 China Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.4 Europe Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.5 Japan Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.7 India Neuromodulation Devices Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Neuromodulation Devices (2012-2022)
        1.5.1 Global Neuromodulation Devices Sales and Growth Rate (2012-2022)
        1.5.2 Global Neuromodulation Devices Revenue and Growth Rate (2012-2022)

2 Global Neuromodulation Devices Competition by Players/Suppliers, Type and Application
     2.1 Global Neuromodulation Devices Market Competition by Players/Suppliers
        2.1.1 Global Neuromodulation Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Neuromodulation Devices Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Neuromodulation Devices (Volume and Value) by Type
        2.2.1 Global Neuromodulation Devices Sales and Market Share by Type (2012-2017)
        2.2.2 Global Neuromodulation Devices Revenue and Market Share by Type (2012-2017)
    2.3 Global Neuromodulation Devices (Volume and Value) by Region
        2.3.1 Global Neuromodulation Devices Sales and Market Share by Region (2012-2017)
        2.3.2 Global Neuromodulation Devices Revenue and Market Share by Region (2012-2017)
    2.4 Global Neuromodulation Devices (Volume) by Application

3 United States Neuromodulation Devices (Volume, Value and Sales Price)
    3.1 United States Neuromodulation Devices Sales and Value (2012-2017)
        3.1.1 United States Neuromodulation Devices Sales and Growth Rate (2012-2017)
        3.1.2 United States Neuromodulation Devices Revenue and Growth Rate (2012-2017)
        3.1.3 United States Neuromodulation Devices Sales Price Trend (2012-2017)
    3.2 United States Neuromodulation Devices Sales Volume and Market Share by Players
    3.3 United States Neuromodulation Devices Sales Volume and Market Share by Type
    3.4 United States Neuromodulation Devices Sales Volume and Market Share by Application

4 China Neuromodulation Devices (Volume, Value and Sales Price)
    4.1 China Neuromodulation Devices Sales and Value (2012-2017)
        4.1.1 China Neuromodulation Devices Sales and Growth Rate (2012-2017)
        4.1.2 China Neuromodulation Devices Revenue and Growth Rate (2012-2017)
        4.1.3 China Neuromodulation Devices Sales Price Trend (2012-2017)
    4.2 China Neuromodulation Devices Sales Volume and Market Share by Players
    4.3 China Neuromodulation Devices Sales Volume and Market Share by Type
    4.4 China Neuromodulation Devices Sales Volume and Market Share by Application

5 Europe Neuromodulation Devices (Volume, Value and Sales Price)
    5.1 Europe Neuromodulation Devices Sales and Value (2012-2017)
        5.1.1 Europe Neuromodulation Devices Sales and Growth Rate (2012-2017)
        5.1.2 Europe Neuromodulation Devices Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Neuromodulation Devices Sales Price Trend (2012-2017)
    5.2 Europe Neuromodulation Devices Sales Volume and Market Share by Players
    5.3 Europe Neuromodulation Devices Sales Volume and Market Share by Type
    5.4 Europe Neuromodulation Devices Sales Volume and Market Share by Application

6 Japan Neuromodulation Devices (Volume, Value and Sales Price)
    6.1 Japan Neuromodulation Devices Sales and Value (2012-2017)
        6.1.1 Japan Neuromodulation Devices Sales and Growth Rate (2012-2017)
        6.1.2 Japan Neuromodulation Devices Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Neuromodulation Devices Sales Price Trend (2012-2017)
    6.2 Japan Neuromodulation Devices Sales Volume and Market Share by Players
    6.3 Japan Neuromodulation Devices Sales Volume and Market Share by Type
    6.4 Japan Neuromodulation Devices Sales Volume and Market Share by Application

7 Southeast Asia Neuromodulation Devices (Volume, Value and Sales Price)
    7.1 Southeast Asia Neuromodulation Devices Sales and Value (2012-2017)
        7.1.1 Southeast Asia Neuromodulation Devices Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Neuromodulation Devices Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Neuromodulation Devices Sales Price Trend (2012-2017)
    7.2 Southeast Asia Neuromodulation Devices Sales Volume and Market Share by Players
    7.3 Southeast Asia Neuromodulation Devices Sales Volume and Market Share by Type
    7.4 Southeast Asia Neuromodulation Devices Sales Volume and Market Share by Application

8 India Neuromodulation Devices (Volume, Value and Sales Price)
    8.1 India Neuromodulation Devices Sales and Value (2012-2017)
        8.1.1 India Neuromodulation Devices Sales and Growth Rate (2012-2017)
        8.1.2 India Neuromodulation Devices Revenue and Growth Rate (2012-2017)
        8.1.3 India Neuromodulation Devices Sales Price Trend (2012-2017)
    8.2 India Neuromodulation Devices Sales Volume and Market Share by Players
    8.3 India Neuromodulation Devices Sales Volume and Market Share by Type
    8.4 India Neuromodulation Devices Sales Volume and Market Share by Application

9 Global Neuromodulation Devices Players/Suppliers Profiles and Sales Data
    9.1 Medtronic
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Neuromodulation Devices Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Medtronic Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Boston Scientific Corporation
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Neuromodulation Devices Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 St.Jude Medical
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Neuromodulation Devices Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 St.Jude Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Synapse Biomedical
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Neuromodulation Devices Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Nevro
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Neuromodulation Devices Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Nevro Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Neurosigma
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Neuromodulation Devices Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Neurosigma Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Neuropace
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Neuromodulation Devices Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Neuropace Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Neuronetics
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Neuromodulation Devices Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Neuronetics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Cyberonics
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Neuromodulation Devices Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Cyberonics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 BioControl Medical
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Neuromodulation Devices Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview

10 Neuromodulation Devices Maufacturing Cost Analysis
    10.1 Neuromodulation Devices Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Neuromodulation Devices
    10.3 Manufacturing Process Analysis of Neuromodulation Devices

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Neuromodulation Devices Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Neuromodulation Devices Market Forecast (2017-2022)
    14.1 Global Neuromodulation Devices Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Neuromodulation Devices Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Neuromodulation Devices Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Neuromodulation Devices Price and Trend Forecast (2017-2022)
    14.2 Global Neuromodulation Devices Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Neuromodulation Devices Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Neuromodulation Devices Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Neuromodulation Devices Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Neuromodulation Devices Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Neuromodulation Devices Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Neuromodulation Devices Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Neuromodulation Devices Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Neuromodulation Devices Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Neuromodulation Devices Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Neuromodulation Devices Sales Forecast by Type (2017-2022)
       14.3.2 Global Neuromodulation Devices Revenue Forecast by Type (2017-2022)
       14.3.3 Global Neuromodulation Devices Price Forecast by Type (2017-2022)
    14.4 Global Neuromodulation Devices Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer